메뉴 건너뛰기




Volumn 26, Issue 5, 2010, Pages 333-337

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes

Author keywords

Gabapentin; Hot flushes; Post menopause; Transdermal estradiol

Indexed keywords

ESTRADIOL; GABAPENTIN; LINDISC; UNCLASSIFIED DRUG;

EID: 77951125722     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903511539     Document Type: Article
Times cited : (28)

References (31)
  • 1
    • 34250026170 scopus 로고    scopus 로고
    • Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale
    • Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271-278.
    • (2007) Maturitas , vol.57 , pp. 271-278
    • Chedraui, P.1    Aguirre, W.2    Hidalgo, L.3    Fayad, L.4
  • 2
    • 33846864200 scopus 로고    scopus 로고
    • Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome
    • Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161-168.
    • (2007) Arch Gynecol Obstet , vol.275 , pp. 161-168
    • Chedraui, P.1    Hidalgo, L.2    Chavez, D.3    Morocho, N.4    Alvarado, M.5    Huc, A.6
  • 3
    • 27344439508 scopus 로고    scopus 로고
    • Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
    • Utian W. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcome 2005;3:47.
    • (2005) Health Qual Life Outcome , vol.3 , pp. 47
    • Utian, W.1
  • 4
    • 45649083485 scopus 로고    scopus 로고
    • The menopausal hot flush-anything new?
    • Sturdee DW. The menopausal hot flush-anything new? Maturitas 2008;60:42-49.
    • (2008) Maturitas , vol.60 , pp. 42-49
    • Sturdee, D.W.1
  • 5
    • 2342479959 scopus 로고    scopus 로고
    • Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies
    • Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10:507-515.
    • (2003) Menopause , vol.10 , pp. 507-515
    • Keenan, N.L.1    Mark, S.2    Fugh-Berman, A.3    Browne, D.4    Kaczmarczyk, J.5    Hunter, C.6
  • 7
    • 0032853468 scopus 로고    scopus 로고
    • Reduced thermoregulatory null zone in postmenopausal women with hot flashes
    • Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999;181:66-70.
    • (1999) Am J Obstet Gynecol , vol.181 , pp. 66-70
    • Freedman, R.R.1    Krell, W.2
  • 8
    • 0023204660 scopus 로고
    • Thermoregulatory physiology of menopausal hot flashes: A review
    • Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Can J Physiol Pharmacol 1987;65:1312-1324.
    • (1987) Can J Physiol Pharmacol , vol.65 , pp. 1312-1324
    • Kronenberg, F.1    Downey, J.A.2
  • 9
    • 16644402955 scopus 로고    scopus 로고
    • Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
    • Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004;18:CD002978.
    • (2004) Cochrane Database Syst Rev , vol.18
    • MacLennan, A.H.1    Broadbent, J.L.2    Lester, S.3    Moore, V.4
  • 10
    • 1842590509 scopus 로고    scopus 로고
    • Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review
    • Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-1620.
    • (2004) JAMA , vol.291 , pp. 1610-1620
    • Nelson, H.D.1
  • 12
    • 0036290010 scopus 로고    scopus 로고
    • Use of alternative therapies for menopause symptoms: Results of a population-based survey
    • Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100:18-25.
    • (2002) Obstet Gynecol , vol.100 , pp. 18-25
    • Newton, K.M.1    Buist, D.S.2    Keenan, N.L.3    Anderson, L.A.4    Lacroix, A.Z.5
  • 13
    • 4143103439 scopus 로고    scopus 로고
    • Nonestrogen treatment modalities for vasomotor symptoms associated with menopause
    • Fugate SE, Church CO. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother 2004;38:1482-1499.
    • (2004) Ann Pharmacother , vol.38 , pp. 1482-1499
    • Fugate, S.E.1    Church, C.O.2
  • 15
    • 0037311026 scopus 로고    scopus 로고
    • Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial
    • Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-345.
    • (2003) Obstet Gynecol , vol.101 , pp. 337-345
    • Guttuso Jr., T.1    Kurlan, R.2    McDermott, M.P.3    Kieburtz, K.4
  • 17
    • 0029975930 scopus 로고    scopus 로고
    • The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel
    • Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-5776.
    • (1996) J Biol Chem , vol.271 , pp. 5768-5776
    • Gee, N.S.1    Brown, J.P.2    Dissanayake, V.U.3    Offord, J.4    Thurlow, R.5    Woodruff, G.N.6
  • 18
    • 0034122271 scopus 로고    scopus 로고
    • The Menopause Rating Scale (MRS): Comparison with Kupperman index and quality-of-life scale SF-36
    • Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric 2000;3:50-58.
    • (2000) Climacteric , vol.3 , pp. 50-58
    • Schneider, H.P.1    Heinemann, L.A.2    Rosemeier, H.P.3    Potthoff, P.4    Behre, H.M.5
  • 19
    • 77951107110 scopus 로고    scopus 로고
    • http://www-users.york.ac.uk/*mb55/index.html.
  • 21
    • 34848812304 scopus 로고    scopus 로고
    • Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: A randomized controlled trial
    • Bachmann GA, Schaefers M, Uddin A, Utian WH. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2007;110:771-779.
    • (2007) Obstet Gynecol , vol.110 , pp. 771-779
    • Bachmann, G.A.1    Schaefers, M.2    Uddin, A.3    Utian, W.H.4
  • 22
    • 41949103042 scopus 로고    scopus 로고
    • Both low-dose and microdose 17beta-oestradiol reduced hot flushes
    • Andrews J. Both low-dose and microdose 17beta-oestradiol reduced hot flushes. Evid Based Med 2008;13:43.
    • (2008) Evid Based Med , vol.13 , pp. 43
    • Andrews, J.1
  • 23
    • 59949105821 scopus 로고    scopus 로고
    • Use of gabapentin in patients experiencing hot flashes
    • Brown JN, Wright BR. Use of gabapentin in patients experiencing hot flashes. Pharmacotherapy 2009;29:74-81.
    • (2009) Pharmacotherapy , vol.29 , pp. 74-81
    • Brown, J.N.1    Wright, B.R.2
  • 24
    • 33745947782 scopus 로고    scopus 로고
    • Mechanisms of the antinociceptive action of gabapentin
    • Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 2006;100:471-486.
    • (2006) J Pharmacol Sci , vol.100 , pp. 471-486
    • Cheng, J.K.1    Chiou, L.C.2
  • 26
    • 40449101303 scopus 로고    scopus 로고
    • Gabapentin for the treatment of menopausal hot flashes: A ramdomized controlled trial
    • Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a ramdomized controlled trial. Menopause 2008;15:310-318.
    • (2008) Menopause , vol.15 , pp. 310-318
    • Butt, D.A.1    Lock, M.2    Lewis, J.E.3    Ross, S.4    Moineddin, R.5
  • 27
    • 0034673943 scopus 로고    scopus 로고
    • Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester Cancer Center Community Clinical Oncology Program study
    • Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, Pierce HI, Dragalin V, Morrow GR. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000;132:788-793.
    • (2000) Ann Intern Med , vol.132 , pp. 788-793
    • Pandya, K.J.1    Raubertas, R.F.2    Flynn, P.J.3    Hynes, H.E.4    Rosenbluth, R.J.5    Kirshner, J.J.6    Pierce, H.I.7    Dragalin, V.8    Morrow, G.R.9
  • 29
    • 0037976797 scopus 로고    scopus 로고
    • Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial
    • Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289: 2827-2834.
    • (2003) JAMA , vol.289 , pp. 2827-2834
    • Stearns, V.1    Beebe, K.L.2    Iyengar, M.3    Dube, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.